Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02724241 · ClinicalTrials.gov registry record · NA

E-Cigarettes and SNA

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT02724241 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02724241, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, and sham control, on sympathetic nerve activity and markers of oxidative stress.

Interventions

  • OTHER one time exposure to e-cig with nicotine
  • OTHER One time exposure to e-cigarette without nicotine
  • OTHER one time exposure to empty e-cigarette

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-04
Est. Completion 2021-12
Phase NA

What the Registry Record Tells You About NCT02724241

The ClinicalTrials.gov registry entry for NCT02724241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which one time exposure to e-cig with nicotine is the first listed.

NCT02724241 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02724241 about?

NCT02724241 is a clinical study titled "E-Cigarettes and SNA". Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, and sham control, on sympathetic nerve activity and markers of oxidative stress.

What is the current status of trial NCT02724241?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-04. Estimated completion is 2021-12.

What interventions are being tested in trial NCT02724241?

The interventions under investigation include: one time exposure to e-cig with nicotine (OTHER), One time exposure to e-cigarette without nicotine (OTHER), one time exposure to empty e-cigarette (OTHER).

Who is sponsoring clinical trial NCT02724241?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.